Product Information
TIADYLT ER 360 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.3432 per EA under NDC 68382074916. Its NADAC has been published 354 times since Dec 25, 2019.
FDA first approved this application on Aug 11, 2017. Its Orange Book therapeutic-equivalence code is AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
360 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382074916
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206641FDA Approved
8/11/2017
TE Code
AB4
On Market Since
11/8/2017
Pharmacological Classes
Price Statistics
The NADAC for TIADYLT ER 360 MG CAPSULE has been published 354 times since Dec 25, 2019, and over the history we have for it it has declined 38.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3432 per EA |
|---|---|
| All-time high | $0.8016 (Sep 16, 2020) |
| All-time low | $0.3103 (Jul 22, 2026) |
| 52-week high | $0.5732 |
| 52-week low | $0.3103 |
| Median price | $0.5754 |
| Average price | $0.5581 |
| Largest weekly change | +50.1% (Apr 22, 2020) |
| Weeks tracked | 354 |
| Tracking since | Dec 25, 2019 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diltiazem hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIADYLT ER 360 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIADYLT ER 360 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.3432 per EA (NDC 68382074916), effective Sep 30, 2026.
How has the price of TIADYLT ER 360 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIADYLT ER 360 MG CAPSULE has declined 38.5%. It has been tracked across 354 weekly CMS publications since Dec 25, 2019.
What are the highest and lowest recorded NADAC prices for TIADYLT ER 360 MG CAPSULE?
Since Dec 25, 2019, the NADAC for TIADYLT ER 360 MG CAPSULE has ranged from a low of $0.3103 (Jul 22, 2026) to a high of $0.8016 (Sep 16, 2020), with a median of $0.5754 per EA.
Are there cheaper alternatives to TIADYLT ER 360 MG CAPSULE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 24H ER(CD) 360 MG CP, is $0.3327 per EA — about 3% below TIADYLT ER 360 MG CAPSULE.
Who manufactures TIADYLT ER 360 MG CAPSULE?
TIADYLT ER 360 MG CAPSULE (NDC 68382074916) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.